InvestorsHub Logo
Followers 36
Posts 5775
Boards Moderated 0
Alias Born 02/20/2015

Re: None

Thursday, 07/26/2018 8:41:59 AM

Thursday, July 26, 2018 8:41:59 AM

Post# of 2498
HOME RUN!!!

CorMedix price target raised to $3 from $2 at H.C. Wainwright H.C. Wainwright analyst Raghuram Selvaraju raised his price target for CorMedix to $3 saying the Neutrolin interim readout delivered a "home run." The analyst sees a possibility now for Neutrolin to be filed before the end of this year and to be approved in 2019, versus his original assumption that the drug would not enter the U.S. market prior to 2020. Further, the news of the clear efficacy signal in the LOCK-IT-100 study could meaningfully accelerate ex-U.S. sales of the product, the analyst adds. He reiterates a Buy rating on CorMedix.

Read more at:
https://thefly.com/landingPageNews.php?id=2764589
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRMD News